{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:20:08Z","timestamp":1789870808405,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sumitomo Dainippon Pharma Co., Ltd (Osaka, Japan)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ejphar.2014.09.023","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T11:00:47Z","timestamp":1411470047000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Zonisamide suppresses endoplasmic reticulum stress-induced neuronal cell damage in vitro and in vivo"],"prefix":"10.1016","volume":"746","author":[{"given":"Saori","family":"Tsujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsue","family":"Ishisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Shimazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.09.023_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","article-title":"Mitochondria, oxidative damage, and inflammation in Parkinson\u05f3s disease","volume":"991","author":"Beal","year":"2003","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejphar.2014.09.023_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1139\/o80-141","article-title":"Effects of acute hepatic ischemia on the electrophoretic patterns of the polypeptides and phosphopolypeptides of the microsomal membrane fraction of rat liver","volume":"58","author":"Behar-Bannelier","year":"1980","journal-title":"Can. J. Biochem."},{"key":"10.1016\/j.ejphar.2014.09.023_bib3","first-page":"241","article-title":"Oxidative stress: a role in the pathogenesis of Parkinson\u05f3s disease","volume":"29","author":"Gotz","year":"1990","journal-title":"J Neural Transm."},{"key":"10.1016\/j.ejphar.2014.09.023_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nbd.2014.03.004","article-title":"Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson\u05f3s disease","volume":"67","author":"Gyoneva","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2014.09.023_bib5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1248\/yakushi.12-00249","article-title":"[Molecular pharmacological studies on the protection mechanism against endoplasmic reticulum stress-induced neurodegenerative disease]","volume":"132","author":"Kaneko","year":"2012","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ejphar.2014.09.023_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2010.06.058","article-title":"Zonisamide reduces cell death in SH-SY5Y cells via an anti-apoptotic effect and by upregulating MnSOD","volume":"481","author":"Kawajiri","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2014.09.023_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2014.05.042","article-title":"Down-regulation of GRP78 enhances apoptosis via CHOP pathway in retinal ischemia-reperfusion injury","volume":"575","author":"Li","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2014.09.023_bib8","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1038\/cddis.2012.71","article-title":"Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress","volume":"3","author":"Mecha","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2014.09.023_bib9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.5692\/clinicalneurol.50.780","article-title":"[Discovery of an antiparkinsonian drug: zonisamide]","volume":"50","author":"Murata","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.ejphar.2014.09.023_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","article-title":"Zonisamide improves motor function in Parkinson disease; a randomized, double-blined study","volume":"68","author":"Murata","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2014.09.023_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2006.01.116","article-title":"Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain","volume":"1082","author":"Oida","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2014.09.023_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12031-011-9638-8","article-title":"HRD1 levels increased by zonisamide prevented cell death and caspase-3 activation caused by endoplasmic reticulum stress in SH-SY5Y cells","volume":"46","author":"Omura","year":"2012","journal-title":"J Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2014.09.023_bib13","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.bbadis.2013.04.009","article-title":"Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death","volume":"1832","author":"Parra","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2014.09.023_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.310.6979.575","article-title":"Drug treatment of Parkinson\u05f3s disease","volume":"310","author":"Quinn","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2014.09.023_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0006-8993(89)91689-2","article-title":"D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour","volume":"503","author":"Robertson","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2014.09.023_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tcb.2003.11.001","article-title":"A trip to the ER: coping with stress","volume":"14","author":"Rutkowski","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2014.09.023_bib17","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1523\/JNEUROSCI.22-24-10690.2002","article-title":"Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson\u05f3s disease","volume":"22","author":"Ryu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.09.023_bib18","unstructured":"Sumitomo Dainippon Pharma Co., Ltd., 8th edition revision. Pharmaceuticals interview form, Levodopa activation type therapeutic agent for Parkinson\u05f3s disease TRERIEF\u00ae Tablet 25mg, Item VII Pharmacokinetics, 2014. August"},{"key":"10.1016\/j.ejphar.2014.09.023_bib19","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of Parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2014.09.023_bib20","first-page":"159160","article-title":"Mitochondrial contribution to Parkinson\u05f3s disease pathogenesis","volume":"2011","author":"Schapira","year":"2011","journal-title":"Parkinson Dis."},{"key":"10.1016\/j.ejphar.2014.09.023_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-1211(92)90087-A","article-title":"Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex","volume":"12","author":"Suzuki","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2014.09.023_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ncb2408","article-title":"Toll-like receptor activation suppresses ER stress factor CHOP and translation inhibition through activation of eIF2B","volume":"14","author":"Woo","year":"2012","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2014.09.023_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1254\/jphs.09019FP","article-title":"Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP","volume":"110","author":"Yabe","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.09.023_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2010.09.081","article-title":"Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity","volume":"650","author":"Yamauchi","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2014.09.023_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1373\/clinchem.2007.097725","article-title":"Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease","volume":"54","author":"Zhu","year":"2008","journal-title":"Clin. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400675X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400675X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T08:38:45Z","timestamp":1565858325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400675X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":25,"alternative-id":["S001429991400675X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.023","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zonisamide suppresses endoplasmic reticulum stress-induced neuronal cell damage in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}